Solid Biosciences annual operating margin
2021
2022
Solid Biosciences Operating Margin Growth & History (SLDB)
Solid Biosciences's operating margin was −1,315.20% for fiscal 2022.
View full Solid Biosciences company overviewSolid Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −1,315.20% | −784.70 pp |
| 2021 | 2021-12-31 | −530.50% | — |
Solid Biosciences quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Solid Biosciences operating margin trends
Across the available reported history, Solid Biosciences's operating margin decreased from −530.50% to −1,315.20%, a change of −784.70 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Solid Biosciences filings at SEC.gov ↗